Synovial fluid markers in osteoarthritis

Rheumatic Disease Clinics of North America

Volumn 25, Issue 2, 1999, Pages 433-449

  Myers, S L ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICULAR CARTILAGE; DISEASE COURSE; DISEASE MARKER; HUMAN; JOINT CAVITY; MACROMOLECULE; METABOLISM; OSTEOARTHRITIS; PATHOLOGY; PRIORITY JOURNAL; REVIEW; SYNOVIAL FLUID; TISSUE INJURY; TISSUE REPAIR;

EID: 0033038756     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70077-6     Document Type: Article

References (99)

1. L. Ayoub S. Myers R. Burt Repeated measurements of synovial clearance of technetium 99m albumin in the osteoarthritic knee Arthritis Rheum 41 suppl 1 1998 89
2. X. Ayral M. Dougados V. Listrat Arthroscopic evaluation of chondropathy in osteoarthritis of the knee J Rheumatol 23 1996 698 706
3. J.C. Balblanc T. Conrozier P. Matheiu Serum phosphatase A2 activity in osteoarthritis Rev Rhum Engl Ed 61 1994 289 296
4. C. Belcher R. Yaqub F. Fawthrop Synovial fluid chondroitin and keratan sulfate epitopes, glycosaminoglycans and hyaluronan in arthritic and normal knees Ann Rheum Dis 56 1997 299 307
5. R.C. Billinghurst L. Dahlberg M. Ionescu Enhanced cleavage of type II collagen by collagenases in osteoarthritic cartilage J Clin Invest 99 1997 1534 1545
6. K.D. Brandt E.M. Braunstein Visco D.M. Cranial (anterior) cruciate ligament transection in the dog: A bona fide model of osteoarthritis, not merely of cartilage injury and repair J Rheumatol 18 1991 436 446
7. Brandt K. Thonar E.J.-M.A. Lack of association between serum keratan sulfate concentrations and cartilage changes of osteoarthritis after transection of the anterior cruciate ligament in the dog Arthritis Rheum 32 1989 647 651
8. K.D. Brandt A pessimistic view of serologic “markers” for diagnosis and management of osteoarthritis. Biochemical, immunological and clinicopathological perspectives J Rheumatol 16 1989 39 42
9. K.D. Brandt Toward pharmacologic modification of joint damage in osteoarthritis Ann Intern Med 122 1995 874 875
10. T.J. Brown U.B.G. Laurent J.R.E. Fraser Turnover of hyaluronan in synovial joints: Elimination of labeled hyaluronan from the knee joint of the rabbit Exp Physiol 76 1991 125 134
11. P.G. Bullough The pathogenesis of osteoarthritis Moskowit R.W. Howell D.S. Goldberg V.M. Osteoarthritis: Diagnosis and Medical/Surgical Management 1992 WB Saunders Philadelphia 36 69
12. B. Cameron A. Buchgraber H. Passler The natural history of the anterior cruciate ligament-deficient knee. Changes in synovial fluid cytokine and keratan sulfate concentrations Am J Sports Med 25 1997 751 754
13. G.V. Campion F. McCrae T.J. Schnitzer Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee Arthritis Rheum 34 1991 1254 1259
14. G.J. Carroll M.C. Bell B.A. Laing Reduction of the concentration and total amount of keratan sulphate in synovial fluid from patients with osteoarthritis during treatment with piroxicam Ann Rheum Dis 51 1992 850 854
15. B. Caterson C.E. Hughes P. Roughley Anabolic and catabolic markers of proteoglycan metabolism in osteoarthritis Acta Orthop Scand 66 suppl 266 1995 121 123
16. T.E. Cawson V. Curry S. Ramsey The levels of collagenase, tissue inhibitor of metalloproteinases-1 (TIMP-1), collagenase approximately TIMP-1 complexes and glycosaminoglycan (GAG) in sequential samples of synovial fluid aspirated from patients with osteoarthritis Clin Exp Rheumatol 13 1995 431 437
17. X. Chevalier Is a biological marker for osteoarthritis within reach? Rev Rhum Engl Ed 64 1997 562 577
18. I.M. Clark L.K. Powell S. Ramsey The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis Arthritis Rheum 36 1993 372 379
19. T.F. Cruz A.J. Malcomb M.E. Adams Effect of maturation and anterior cruciate ligament transection on the level of keratan sulfate in the serum of dogs J Rheumatol 16 1989 1345 1350
20. L. Dahlberg H. Roos T. Saxne Cartilage metabolism in the injured and uninjured knee of the same patient Ann Rheum Dis 53 1994 823 827
21. L. Dahlberg L. Ryd D. Heinegard Proteoglycan fragments in joint fluid: Influence of arthrosis and inflammation Acta Orthop Scand 63 1992 417 423
22. F. Fawthorp R. Yaqub C. Belcher Chondroitin and keratan sulfate epitopes, glycosaminoglycans, and hyaluronan in progressive versus non-progressive osteoarthritis Ann Rheum Dis 56 1997 119 122
23. R.S. Fife K.D. Brandt E.M. Braunstein 1991. The presence of CMGP in serum determined by immunolocation analysis is not a sensitive indicator of “early” OA of the knee J Lab Clin Med 117 1991 332 338
24. L. Flygare M. Wendel T. Saxne Cartilage matrix macromolecules in lavage fluid of temporomandibular joints before and 6 months after diskectomy Eur J Oral Sci 105 1997 369 372
25. R.L. Goldberg M.E. Lenz J. Huff Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis Arthritis Rheum 34 1991 799 807
26. R.T. Goldman G.R.E. Scuderi M.A. Kelly Arthroscopic treatment of the degenerative knee in older athletes Clin Sports Med 16 1997 51 68
27. N.M. Hadler M.A. Napier Structure of hyaluronic acid in synovial fluid and its influence on the movement of solutes Semin Arthritis Rheum 7 1977 141 152
28. N. Hauser J. Geiss M. Neidhart Distribution of CMP and COMP in human cartilage Acta Orthop Scand 66 suppl 266 1995 71 73
29. C.W. Hay Q. Chu S.C. Budsberg Synovial fluid interleukin 6, tumor necrosis factor, and nitric oxide values in dogs with osteoarthritis secondary to cranial cruciate ligament rupture Am J Vet Res 58 1997 1027 1032
30. H.H. Heilmann K. Lindehayn H.U. Walther Synovial volume of healthy and arthrotic human knee joints Z Orthop Ihre Grenzgeb 134 1996 144 148
31. A.P. Hollander T.F. Heathfield C. Webber Increased damage to type II collagen in osteoarthritic cartilage detected by a new immunoassay J Clin Invest 93 1994 1722 1732
32. D. Jovanovic J.P. Caron J. Martel-Pelletier The therapeutic effects of tenidap in canine experimental osteoarthritis: Relationship with biochemical markers J Rheumatol 24 1997 916 925
33. T. Kobayashi Y. Yoshihara A. Samura Synovial fluid concentrations of the C-propeptide of type II collagen correlate with body mass index in primary knee osteoarthritis Ann Rheum Dis 56 1997 500 503
34. E. Kubota H. Imamura T. Kubota Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the tempomandibular joint J Oral Maxillofac Surg 55 1997 20 27
35. M.W. Lark E.K. Bayne L.S. Lohmander Aggrecan degradation in osteoarthritis and rheumatoid arthritis Acta Orthop Scand 66 suppl 266 1995 92 97
36. M.W. Lark J.T. Gordy J.R. Weidner Cell mediated catabolism of aggrecan. Evidence that cleavage of the Glu373-Ala374 bond is the primary proteolytic event in chondrocyte-mediated catabolism of the aggrecan interglobular domain J Biol Chem 270 1995 2550 2556
37. T.C. Laurent J.R.E. Fraser Hyaluronan FASEB J 6 1992 2397 2404
38. M. Lequesne K. Brandt N. Bellamy Guidelines for testing slow-acting and disease-modifying drugs in osteoarthritis J Rheumatol 21 suppl 4 1994 65 71
39. J.R. Levick The “clearance” of macromolecular substances such as cartilage markers from synovial fluid and serum Maroudas A. Kuettner K. Methods in Cartilage Research 1990 Academic Press San Diego 352 362
40. J.R. Levick Synovial fluid: determinants of volume turnover and material concentration Kuettner K. Schleyerbach R. Peyron J.G. Articular Cartilage and Osteoarthritis 1992 Raven Press New York 529 541
41. J.R. Levick Synovial fluid hydraulics Science and Med 3 1996 52 61
42. E. Lindqvist T. Saxne Cartilage macromolecules in knee joint synovial fluid. Markers of the disease course in patients with acute oligoarthritis Ann Rheum Dis 56 1997 751 753
43. J. Lohmander J.D. Sandy A.H. Plaas Pathways of aggrecan processing in joint tissues Acta Orthop Scand 66 suppl 266 1995 26 32
44. L.S. Lohmander Articular cartilage and osteoarthritis. The role of molecular markers to monitor breakdown, repair and disease J Anat 184 1994 477 492
45. L.S. Lohmander L. Dahlberg D. Eyre Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities Osteoarthritis Cartilage 6 1998 351 361
46. L.S. Lohmander D.T. Felson Defining and validating the clinical role of molecular markers in osteoarthritis Brandt K.D. Doherty M. Lohmander L.S. Osteoarthritis 1998 Oxford University Press Oxford 519 530
47. L.S. Lohmander L.A. Hoerrner L. Dahlberg Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis Arthritis Rheum 36 1994 181 189
48. L.S. Lohmander T. Saxne D.K. Heinegard Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis Ann Rheum Dis 53 1994 8 13
49. L.S. Lohmander Y. Yoshihara H. Roos Procollagen II C-propeptide in joint fluid: Changes in concentration with age, time after knee injury, and osteoarthritis J Rheumatol 23 1996 17656 17659
50. D.H. Manicourt N. Fujimoto K. Obata Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex-related differences in normal subjects and relationship to the extent of joint involvement serum levels of antigenic keratan sulfate in patients with osteoarthritis Arthritis Rheum 37 1994 1774 1783
51. Manicort D.H. Lenz M.-E. E.J. Thonar Levels of serum keratan sulfate rise rapidly and remain elevated following anterior cruciate ligament transection in the dog J Rheumatol 18 1991 1872 1877
52. B. Mansson D. Carey M. Alini Cartilage and bone metabolism in rheumatoid arthritis. Difference between rapid and slow progression of disease identified by serum markers of cartilage metabolism J Clin Invest 95 1995 1071 1077
53. S. Mazzuca K.D. Brandt B.P. Katz Is conventional radiography suitable for evaluation of a disease-modifying drug in patients with knee OA? Osteoarthritis Cartilage 5 1997 217 226
54. A. Mohamed S. Myers K. Brandt Clearance of non-aggregating proteoglycan monomers (MPG) from the normal knee is comparable to clearance of albumin Arthritis Rheum 40 suppl 1 1997 184
55. G. Murphy Matrix metalloproteinases and their inhibitors Acta Orthop Scand 66 suppl 266 1995 55 60
56. S.L. Myers K.D. Brandt Effects of synovial fluid hyaluronan concentration and molecular size on clearance of protein from the canine knee J Rheumatol 22 1995 1732 1739
57. S.L. Myers K.D. Brandt O. Eilam Low grade synovitis accelerates clearance of protein from the knee. Implications for measurement of synovial fluid “markers” in osteoarthritis Arthritis Rheum 38 1995 1085 1091
58. S.L. Myers K.D. Brandt A. Mohammed Synovial fluid aggrecan concentration in osteoarthritis is inversely related to the clearance rate but not related to the severity of cartilage ulceration Trans Orthop Res Soc 23 1998 861
59. S.L. Myers K. Dines D.A. Brandt Experimental assessment by high frequency ultrasound of articular cartilage thickness and OA changes J Rheumatol 22 1995 109 116
60. S.L. Myers B.L. O'Connor K.D. Brandt Accelerated clearance of albumin from the osteoarthritic knee: Implications for interpretation of concentrations of “cartilage markers” in synovial fluid J Rheumatol 23 1996 1744 1748
61. J. Neidel M. Schulze J. Lindschau Association between degree of bone-erosion and synovial fluid levels of tumor necrosis factor alpha in the knee joints of patients with rheumatoid arthritis Inflamm Res 44 1995 217 221
62. M. Neidhart N. Hauser M. Paulsson Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation Br J Rheumatol 36 1997 1151 1160
63. M. Osstergaard P. Gidown M.B. Stoltenberg Volumes of synovial membrane and joint effusion determined by MR imaging Markers of severity and/or activity in rheumatoid arthritis? Ugeskr Laeger 159 1997 3956 3961
64. I.G. Otterness R.O. Zimmerer A.C. Swindell An examination of some molecular markers in blood and urine for discriminating patients with OA from healthy individuals Acta Orthop Scand 66 suppl 266 1995 148 150
65. C.G. Peterfy Magnetic resonance imaging Brandt K.D. Doherty M. Lohmander L.S. Osteoarthritis 1998 Oxford University Press Oxford 473 494
66. I.F. Petersson T. Boegard J. Dahistrom Changes in serum levels of cartilage and bone markers in early osteoarthritis of the knee Acta Orthop Scand 66 suppl 266 1995 144 145
67. I.F. Petersson T. Boegard J. Dahlstrom Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis Osteoarthritis Cartilage 6 1998 33 39
68. I.F. Petersson L. Sandqvist B. Svensson Cartilage markers in synovial fluid in symptomatic knee osteoarthritis Ann Rheum Dis 56 1997 64 67
69. A.R. Poole M. Ionescu A. Swan Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan—Implications for pathogenesis J Clin Invest 94 1994 25 33
70. A.R. Poole G. Rizkalla M. Ionescu Increased content of the c-propeptide of type II collagen in OA human cartilage Trans Orthop Res Soc 16 1991 343
71. J.W. Pritchett Substance P level in synovial fluid may predict pain relief after knee replacement J Bone Joint Surg 79 1997 114 116
72. A. Ratcliffe P.J. Beauvis F. Saed-Nejad Synovial fluid analyses detect and differentiate proteoglycan metabolism in canine experimental models of osteoarthritis and disuse atrophy Agents Actions 39 suppl 1 1993 63 67
73. A. Ratcliffe M.E. Billingham F. Saed-Nejad Increased release of matrix components from articular cartilage in experimental canine osteoarthritis J Orthop Res 10 1992 350 358
74. A. Ratcliffe M.J. Seibel Biochemical markers of osteoarthritis Curr Opin Rheumatol 2 1990 770 776
75. A. Ratcliffe W. Shurety B. Caterson The quantitation of a native chondroitin sulphate epitope in synovial fluid lavages and articular cartilage from canine experimental osteoarthritis and disuse atrophy Arthritis Rheum 36 1993 543 550
76. H. Roos L. Dahlberg L.A. Hoerrner Markers of cartilage matrix metabolism in human joint fluid and serum: The effect of exercise Osteoarthritis Cartilage 3 1995 7 14
77. C. Salisbury M. Sharif Relations between synovial fluid and serum concentrations of osteocalcin and other markers of joint tissue turnover in the knee joint compared with peripheral blood Ann Rheum Dis 56 1997 558 561
78. M. Samo T. Scott J. Whaley Development of a serum ELISA for YLK-40 and its application in osteoarthritis [abstract] Arthritis Rheum 38 suppl 1 1995 240
79. J.D. Sandy C.R. Flanner P.J. Neame The structure of aggrecan fragments in human synovial fluid: Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the glu 373-ala 374 bond of the interglobular domain J Clin Invest 89 1992 1512 1516
80. T. Saxne D. Heinegard Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions Arthritis Rheum 35 1992 385 390
81. T. Saxne D. Heinegard F.A. Wollheim Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis Lancet 2 1985 127 128
82. T. Saxne L. Zunino D. Heinegard Increased release of bone sialoprotein into synovial fluid reflects tissue destruction in rheumatoid arthritis Arthritis Rheum 38 1995 82 90
83. Schumacher H.R. Jr Z. Meng M. Sieck Effect of a nonsteroidal antiinflammatory drug on synovial fluid in osteoarthritis J Rheumatol 23 1996 1774 1777
84. M. Sharif E. George P.A. Dieppe Correlations between synovial fluid markers of cartilage and bone turnover and scintigraphic scan abnormalities in osteoarthritis of the knee Arthritis Rheum 38 1995 78 81
85. M. Sharif E. George P.A. Dieppe Synovial fluid and serum concentrations of amino-terminal propeptide of type III procollagen in healthy volunteers and patients with joint disease Ann Rheum Dis 55 1996 47 51
86. M. Sharif E. George L. Shepstone Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee Arthritis Rheum 38 1995 760 767
87. M. Shinmei Y. Inamori Y. Yoshihara The potential for cartilage markers in joint fluid for drug evaluation Kuettner K. Schleyerbach R. Peyron J.G. Articular Cartilage and Osteoarthritis 1992 Raven Press New York 597 609
88. M. Shinmei S. Miyauchi A. Machida Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid Arthritis Rheum 35 1992 1304 1308
89. P.A. Simkin J.E. Bassett Cartilage matrix molecules in serum and synovial fluid Curr Opin Rheum 7 1995 346 351
90. P.A. Simkin R.S. Benedict Iodide and albumin kinetics in normal canine wrists and knees Arthritis Rheum 33 1990 73 79
91. R.S. Slater M.T. Bayliss P.F. Lachiewicz Monoclonal antibodies that detect biochemical markers of arthritis in humans Arthritis Rheum 38 1995 655 659
92. Thonar E.G.-M.A. M. Shinmei L.S. Lohmander Body fluid markers of cartilage changes in osteoarthritis Rheum Dis Clin North Am 19 1993 635 657
93. M.D. Tortorella E.C. Arner Fibronectin fragments induce matrix metalloproteinase production and aggrecanase-mediated cartilage degradation Trans Orthop Res Soc 22 1997 106
94. G. Venn J.J. Neitfeld A.J. Duits Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis Arthritis Rheum 36 1993 819 826
95. V. Vilim A.J. Fosang Proteoglycans isolated from dissociative extracts of differently aged human articular cartilages Biochem J 304 1994 887 894
96. W.J. Wallis P.A. Simkin W.B. Nelp Protein traffic in human synovial effusions Arthritis Rheum 30 1987 57 63
97. C.L. Westacott M. Sharif Cytokines in osteoarthritis: Mediators or markers of joint destruction? Semin Arthritis Rheum 25 1996 254 272
98. P. Witsch-Prehm R. Miehlke H. Kresse Presence of small proteoglycan fragments in normal and arthritic human cartilage Arthritis Rheum 35 1992 1042 1052
99. J. Witter P.J. Roughley C. Webber The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis Arthritis Rheum 30 1987 519 529